DARMSTADT, Germany and NEW YORK – Digital therapeutics company Blue Mesa Health is partnering with Merck KGaA to pilot diabetes prevention programs in territories outside of the United States. “We have seen such great success helping people across America prevent or significantly delay the onset of Type 2 diabetes,” said Curtis Duggan, CEO of Blue Mesa Health, in a statement. “We are looking forward to helping more people outside of the United States manage their risk for Type 2 diabetes.” Blue Mesa Health developed two chronic disease prevention programs based on the Center for Disease Control’s Diabetes Prevention Program called Transform, a year-long lifestyle change program that integrates remote health coaching from dieticians, a peer support group and the integration of smartphone app technology with connected bathroom scales and activity trackers. “At Merck we are continuously striving to improve the lives of patients with diabetes, and we believe expanding our current pharmacological portfolio into an integrated disease management offering will have a tremendous impact on treatment outcomes,” said Daniel Ruggiero, head of diabetes strategy at Merck KGaA, in a statement.
You are here: / / Blue Mesa Health partners with Merck KGaA to pilot diabetes prevention programs